Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Health Topics
C2N, Unilabs sign global agreement on early Alzheimer's diagnostics
By
LabPulse.com staff writers
C2N and Unilabs have signed a multiyear agreement that will increase access to C2N's Precivity blood tests for the early diagnosis of Alzheimer's disease to Unilabs' testing network on an exclusive basis.
August 8, 2024
Diagnostic laboratory joint venture expands RNA sequencing at Baylor
By
LabPulse.com staff writers
WT RNAseq goes beyond the interpretation of already identified variants by whole exome sequencing (WES) or whole genome sequencing (WGS), according to Baylor Genetics.
August 6, 2024
ALZpath, Roche sign licensing agreement for dementia biomarker
By
LabPulse.com staff writers
ALZpath has signed a licensing agreement with Roche for the use of the ALZpath pTau217 antibody to develop and commercialize a diagnostic blood test for Alzheimer's disease that will be offered on the Roche Elecsys platform.
June 12, 2024
Study: Model predicts dementia years before clinical diagnosis
By
LabPulse.com staff writers
Researchers have developed a model that predicts dementia up to nine years before a clinical diagnosis. With greater than 80% accuracy, the test is potentially more reliable than current methods in common use for diagnosis.
June 7, 2024
GeneDx launches exome sequencing access program for pediatric epilepsy patients
By
LabPulse.com staff writers
Genetic testing firm GeneDx has launched a patient access program aimed at increasing access to exome sequencing for pediatric patients with epilepsy.
June 5, 2024
BioMérieux TBI test receives FDA 510(k) clearance
By
LabPulse.com staff writers
BioMérieux has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its assay that screens for mild traumatic brain injury, including concussion.
May 29, 2024
Nanopath awarded $4M in SBIR grants
By
LabPulse.com staff writers
Nanopath has announced that it has been awarded two grants worth a total of $4 million in federal funding through the Small Business Innovation Research (SBIR) program.
May 22, 2024
Backlog of unresolved medical diagnoses leads to new method for clinical exome reanalysis
By
Liz Carey
The automated analysis improved the rate of accurate genetic diagnosis, doubling the number of solved cases as compared with benchmarked methods, across three distinct real-world cohorts, according to researchers.
May 16, 2024
BioMarin confirms layoffs and R&D cuts
By
LabPulse.com staff writers
Roctavian, BioMarin's gene therapy for severe hemophilia A, generated $800,000 in net product revenue in the first quarter of 2024.
May 15, 2024
Danaher launches collaboration with Johns Hopkins University on TBI diagnostics
By
LabPulse.com staff writers
Danaher has launched a partnership with Johns Hopkins University aimed at developing new traumatic brain injury (TBI) diagnostics.
May 9, 2024
Vertex to pay $25M upfront to scale cell manufacturing technology
By
LabPulse.com staff writers
As part of the deal, Vertex was also willing to pay up to $215 million in milestones achieved in connection with the development of a scaled-up process for fully differentiated islet cells.
April 25, 2024
Quest adds new biomarker test to Alzheimer's portfolio
By
LabPulse.com staff writers
Quest Diagnostics has launched a new blood biomarker test as part of its AD-Detect portfolio of blood tests for Alzheimer's disease risk assessment.
April 23, 2024
Page 1 of 70
Next Page
